Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Many frozen plasma doses have 'unproven clinical benefit'

  • Comment

There is wide variation in dose of fresh frozen plasma (FFP) use by ICU clinicians, according to UK researchers.

They warn that a high proportion of current FFP transfusions are of unproven clinical benefit.

The researchers carried out an eight week observational study in 29 adult ICUs, which included 1,923 admissions, of which 13% received FFP.

Overall, the median FFP dose was 10.8ml kg, but doses varied widely between 7.2 and 14.4ml kg.

The authors added that a “remarkably high proportion of FFP was administered to patients without evidence of bleeding”.

Critical Care (2011) 15: R108

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.